Table 3.

Proportion of subjects with AKI based on clinical adjudication (CAC) versus the KDIGO AKI consensus criteria

KDIGO
(−)(+)TotalAgreement
CAC
 No AKI (1/3 or 0/3)330 (80.9%)7 (1.7%)337 (82.6%)97.9%
 AKI (2/3 or 3/3)6 (1.5%)65 (15.9%)71 (17.4%)91.5%
 Total336 (82.4%)72 (17.6%)408 (100%)96.8%
KDIGO
(−)(+)TotalAgreement
CAC
 No AKI (1/3 or 0/3)330 (80.9%)7 (1.7%)337 (82.6%)97.9%
 AKI (2/3 or 3/3)6 (1.5%)65 (15.9%)71 (17.4%)91.5%
 Total336 (82.4%)72 (17.6%)408 (100%)96.8%

For the purposes of this study, those with KDIGO Stage 1 AKI were not considered to have AKI. Agreement was present if the clinical adjudication committee adjudicated that AKI was not present and the maximum KDIGO stage was 0 or 1 or if the clinical adjudication committee adjudicated that AKI was present and the maximum KDIGO stage was 2 or 3.

Table 3.

Proportion of subjects with AKI based on clinical adjudication (CAC) versus the KDIGO AKI consensus criteria

KDIGO
(−)(+)TotalAgreement
CAC
 No AKI (1/3 or 0/3)330 (80.9%)7 (1.7%)337 (82.6%)97.9%
 AKI (2/3 or 3/3)6 (1.5%)65 (15.9%)71 (17.4%)91.5%
 Total336 (82.4%)72 (17.6%)408 (100%)96.8%
KDIGO
(−)(+)TotalAgreement
CAC
 No AKI (1/3 or 0/3)330 (80.9%)7 (1.7%)337 (82.6%)97.9%
 AKI (2/3 or 3/3)6 (1.5%)65 (15.9%)71 (17.4%)91.5%
 Total336 (82.4%)72 (17.6%)408 (100%)96.8%

For the purposes of this study, those with KDIGO Stage 1 AKI were not considered to have AKI. Agreement was present if the clinical adjudication committee adjudicated that AKI was not present and the maximum KDIGO stage was 0 or 1 or if the clinical adjudication committee adjudicated that AKI was present and the maximum KDIGO stage was 2 or 3.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close